APA (7th ed.) Citation

R, A., OPB, W., NS, R., A, K., M, K., I, S., . . . TA, T. (2026). HER2-targeted PET-imaging with [68Ga]Ga-ABY-025 to predict targeted-therapy response in HER2-expressing metastatic breast cancer: Study protocol of a multicenter, prospective, open-label trial. Frontiers in oncology, 16, 1812711. https://doi.org/10.3389/fonc.2026.1812711

Chicago Style (17th ed.) Citation

R, Altena, et al. "HER2-targeted PET-imaging with [68Ga]Ga-ABY-025 to Predict Targeted-therapy Response in HER2-expressing Metastatic Breast Cancer: Study Protocol of a Multicenter, Prospective, Open-label Trial." Frontiers in Oncology 16 (2026): 1812711. https://doi.org/10.3389/fonc.2026.1812711.

MLA (9th ed.) Citation

R, Altena, et al. "HER2-targeted PET-imaging with [68Ga]Ga-ABY-025 to Predict Targeted-therapy Response in HER2-expressing Metastatic Breast Cancer: Study Protocol of a Multicenter, Prospective, Open-label Trial." Frontiers in Oncology, vol. 16, 2026, p. 1812711, https://doi.org/10.3389/fonc.2026.1812711.